silybin has been researched along with deoxyglucose in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Digel, M; Füllekrug, J; Küch, EM; Stremmel, W; Zhan, T | 1 |
| Bamezai, RN; Chattopadhyay, S; Iqbal, MA; Khan, A; Prakasam, G; Siddiqui, FA; Siddiqui, S; Sultana, S; Ur Rehman, A | 1 |
2 other study(ies) available for silybin and deoxyglucose
| Article | Year |
|---|---|
Silybin and dehydrosilybin decrease glucose uptake by inhibiting GLUT proteins.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Cell Survival; CHO Cells; Cricetinae; Cricetulus; Deoxyglucose; Enzyme Assays; Glucose; Glucose Transporter Type 4; GTPase-Activating Proteins; Hexokinase; Humans; Hypoglycemic Agents; Insulin; Mice; Oncogene Protein v-akt; Phosphorylation; Protein Transport; Recombinant Fusion Proteins; Silybin; Silymarin | 2011 |
Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Databases, Genetic; Datasets as Topic; Deoxyglucose; Drug Synergism; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Metabolome; Paclitaxel; Proto-Oncogene Proteins c-myc; Signal Transduction; Silybin; Survival Analysis; Triple Negative Breast Neoplasms | 2021 |